The effect of hyperbaric oxygen on growth and chemosensitivity of metastatic prostate cancer

Anticancer Research

Volumn 18, Issue 1 A, 1998, Pages 363-367

  Kalns, John ^a   Krock, Larry ^a   Piepmeier Jr , Edward ^b  

^a Air Force Materiel Command   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Chemotherapy; Hyperbaric oxygen; Prostate cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; PACLITAXEL;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER CELL CULTURE; CANCER GROWTH; CELL COUNT; CHEMOSENSITIVITY; CONTROLLED STUDY; GROWTH RATE; HUMAN; HUMAN CELL; HYPERBARIC OXYGEN; MALE; METASTASIS; MONOLAYER CULTURE; PRESSURE; PRIORITY JOURNAL; PROSTATE CANCER;

ANTIBIOTICS, ANTINEOPLASTIC; CELL DIVISION; CISPLATIN; DOXORUBICIN; HUMANS; HYPERBARIC OXYGENATION; MALE; PACLITAXEL; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0031898936     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Wingo P, Tong T, Bolden S: Cancer Statistics.CA Cancer J Clin 3, 45: 8-30, 1995.
2. Chodak G, Thisted R, Gerber GS, et al: Results of conservative management of clinically localized prostate cancer. N Engl J Med 330: 242-248, 1994.
3. Gann PH, Hennekesn CH, Stampfer, MJ: A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA 273: 289-294, 1995.
4. Mahler C, Denis L: Management of relapsing disease in prostate cancer. Cancer 70: 329, 1992.
5. Slack NH, Murphy GP: A decade of experience with chemotherapy for prostate cancer. Urology 22: 1-10, 1983.
6. Di Sant'Agnesse PA. Neuroendocrine differentiation in human prostatic carcinoma. Hum Pathol 23: 287-296, 1992.
7. Balin AK, Goodman DBP, Rasmussen H, Cristofalo VJ: Oxygen-sensitive stages of-the cell cycle of human diploid cells. J Cell Biology 78: 390-400, 1978.
8. Balin AK, Goodman DBP, Rasmussen H, Cristofalo VJ: The effect of oxygen tension- on the growth and metabolism of WI-38 cells. J Cell Physiol 89: 235-250, 1976.
9. Lian QL, Zhang RC, Yan HF et al: Effects-of hyperbaric oxygen on S-190 sarcoma in mice.; Undersea and Hyperbaric Med 22: 153-160, 1995.
10. Teicher BA, McIntosh-Lowe NL, Rose CM: Effect of various oxygenation conditions and Fluosol-DA on cancer chemotherapuetic agents. Biomat Art Cells Art Org 16: 533-546, 1988.
11. Stone KR, Mickey DD, Wunderli H, Mickey GH: Paulson DF. Isolation of a human prostate carcinoma cell line (DU145). Int J Cancer 21: 274-280, 1978.
12. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW: Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest. Urology 17: 16-22, 1979.
13. Skehan P, Storeng R, Scudiero D et al: New colorimetric cytotoxicity assay for anticancerdrug screening. J Natl Cancer Inst 82: 1107-1112, 1990.
14. Holford NHG, Sheiner LB: Kinetics of pharmacolgic response. Pharmacol Ther 16: 143155, 1982.
15. Sklizovic D, Sanger JR, Kindwall EP, Fink JG, Grunert BK, Campbell BH. Hyperbaric oxygen therapy and squamous cell carcinoma cell line growth. Head and Neck: 75: 236-240, 1993.
16. Headley DB, Gapany M, Dawson DE, Kruse GD, Robinson RA, McCabe BF: The effect of hyperbaric oxygen on growth of human squamous cell carcinoma xenografts. Arch Otolaryngol Head Neck Surg 777: 1269-1972, 1991.
17. Shewell J, Thompson SC: The effect of hyperbaric oxygen treatment on pulmonary metastases in the C3H mouse. Eur J Cancer Clin Oncol 742: 915-922, 1980.
18. Marx RE, Johnson RP: Problem wounds in oral and maxillofacial surgery: the role of hyperbaric oxygen. In: Davis JC Hunt TK eds Problem Wounds: The role of oxygen. New York NY: Elsevier Science Publishing. 65-123, 1988.
19. Suit HD, Smith J, Suchato C: Effect of daily exposure of high pressure oxygen on rumor growth. AJR Am J Roentgenol 97: 1019-1022, 1966.
20. Johnson RE, Kagan AR, Bryant TL: Hyperbaric oxygen effect on experimental tumor growth. Radiology 88: 775-777, 1967.
21. Lindenschmidt RC, Tryka AF, Witschi HP. Inhibition of mouse lung tumor development by hyperoxia. Cancer Res. 46: 1994-2000, 1986.
22. Feldmeier JJ, Heimbach RD, Davolt DA7 Brakora MJ. Sheffield PJ Porter AT: Does hyperbaric oxygen have a cancer-causing or -promoting effect? A review of the pertinent literature. Undersea & Hyperbaric Med 21: 467-475, 1994.
23. Overgaard J: Sensitization of hypoxic tumour cells-clinical experience. Int J Radiat Biol 56: 801-11, 1993.
24. Phillips TL, Wasserman TH: Promise of radiosensitizers and radioprotectors in the treatment of human cancer. Cancer Treat Rep 68: 291-302, 1994.
25. Sealy R. Hyperbaric oxygen in the radiation treatment of head and neck cancers. Radiother Oncol 20 Supplement 1: 75-9, 1988.
26. Teicher BA, Crawford JM, Holden SA, Cathcart KNS: Effects of various oxygenatian conditions on the enhancement of fluosol-DA of Melphalan antitumor activity. Cancer Res 47: 5036-5041, 1987.
27. Alagoz T, Buller RE, Anderson B et al: Evaluation of hyperbaric oxygen as a chemosensitizer in the treatment of epithelial ovarian cancer in xenografts in mice. Cancer 75: 2313-2322, 1995.